Moderna Inc (NAS:MRNA)
$ 128.32 2.65 (2.11%) Market Cap: 49.18 Bil Enterprise Value: 40.89 Bil PE Ratio: 0 PB Ratio: 3.83 GF Score: 68/100

Moderna Inc at Morgan Stanley Healthcare Conference Transcript

Sep 09, 2019 / 08:15PM GMT
Release Date Price: $16.03 (+0.94%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Good afternoon, everybody. We're going to get started with the next session. I am Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Just quickly, before we get started, I need to read a disclosure statement. Please note that all important disclosures including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures, or you can pick up a copy at the registration desk. So very pleased to have Moderna with me for the next presentation and Stéphane Bancel, the CEO. Stéphane, I don't know if you want to make any opening comments or we should just jump right into it.

StÃ;phane Bancel
Moderna, Inc. - CEO & Director

© -

Go, go for it.

Questions & Answers

Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

All right. So I think a couple of high-level platform questions are probably

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot